tiprankstipranks
Trending News
More News >
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market

Compare Shanghai Henlius Biotech, Inc. Class H (2696) vs. Competitors

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$36.41B
40.91
183.90%
1 Buy
0 Hold
0 Sell
Moderate Buy
Zai Lab Ltd
HK$22.18
HK$16.21B
-9.55
-25.21%
5 Buy
2 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$13.48
HK$20.15B
-95.47
155.79%
4 Buy
1 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$23.96
HK$40.05B
-24.53
134.70%
0 Buy
1 Hold
1 Sell
Moderate Sell
Simcere Pharmaceutical Group Limited
HK$12.13
HK$31.54B
31.48
81.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$50.90
HK$20.35B
-14.02
37.20%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2696
Shanghai Henlius Biotech, Inc. Class H
67.00
43.80
188.79%
HK:9688
Zai Lab Ltd
14.51
-4.41
-23.31%
HK:9969
InnoCare Pharma Ltd.
13.48
8.30
160.23%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
25.16
14.86
144.27%
HK:2096
Simcere Pharmaceutical Group Limited
12.15
5.70
88.37%
HK:6855
Ascentage Pharma Group International
54.95
15.25
38.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts